Overview

Leukemia Therapeutics Market is estimated to value over CAGR of over 5.8% during the forecast period 2022 to 2028.

The global leukemia therapeutics market growth is steered by factors, for instance, a plethora of available treatment alternatives for treating chronic myeloid leukemia and high prevalence rate of chronic myeloid leukemia are substantially assisting the market growth. For example, in the United States, there were over 20,000 new cases of chronic myeloid leukemia in 2018. Additionally, the segment growth is guided by the ever-increasing ageing population and increasing research funds for cancer treatments and for developing innovative therapies.

Increasing investments for innovative research and development activities in drug development and discovery, growing overall volume of biotechnology companies and is predicted to spur the augmentation of the market. Likewise, the introduction of advanced therapeutics with fewer side effects and more efficiency, pipeline products awaiting approvals and metabolic inhibitors are projected to steer the market growth throughout the forecast timeframe. Rising awareness amongst patients pertaining to recent advancements in technology and advantages, for instance, safety, tolerability and efficacy are the factors projected to boost the market growth. Current research in molecular diagnosis is anticipated to dominate with the accessibility of various leukemia treatments and is projected to expand the global leukemia therapeutics market size.

Due to the soaring insistence for targeted drugs, they are likely to subjugate the global market over the forecast timeframe. The targeted drugs are prominently used due to their higher success rate and efficacy in comparison with chemotherapy and fewer side effects. These factors are the reason for the rise in their sales over the past few years.

The Asia Pacific region is anticipated to rapidly proliferate owing to numerous incomplete needs in the developing markets, for instance, India, Japan and China and growing investments in the expenditure assigned to the research and development by major biotechnology companies. A healthcare infrastructure that is rapidly growing, high penetration rates of the market and increasing levels of awareness are the major factors contributing to the augmentation of the market in the region.

Key market players are:
Novartis AG, AbbVie, Bristol-Myers Squibb, F. Hoffmann-La Roche, Sanofi, Pfizer, Amgen, Gilead Sciences, Takeda, Celgene.

Leukemia Therapeutics Market Segmentation:

By Type of Leukemia

Chronic Myeloid Leukemia
Chronic Lymphocytic Leukemia
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia

By Treatment Type

Targeted Drugs & Immunotherapy
Chemotherapy

By Molecule Type

Small Molecules
Biologics

By Mode of Administration

Oral Mode
Injectable Mode

By Gender

Males
Females

By Region

North America
Latin America
Europe
Asia-Pacific
Middle East and Africa

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global leukemia therapeutics market by type of leukemia, by treatment type, by molecule type, by mode of administration, by gender and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization services offered are free of charge with purchase of any license of the report.
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com